BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32258115)

  • 1. Berberine Inhibits MDA-MB-231 Cells by Attenuating Their Inflammatory Responses.
    Zhao L; Zhang C
    Biomed Res Int; 2020; 2020():3617514. PubMed ID: 32258115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huaier extract enhances the treatment efficacy of paclitaxel in breast cancer cells via the NF-κB/IκBα pathway.
    Yang L; Song Z; Wang X; Yang W; Wang M; Liu H
    Oncol Rep; 2017 Dec; 38(6):3455-3464. PubMed ID: 29039556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of cellular c-Jun N-terminal protein kinase and NF-κB activation by berberine may result in inhibition of herpes simplex virus replication.
    Song S; Qiu M; Chu Y; Chen D; Wang X; Su A; Wu Z
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5068-78. PubMed ID: 24913175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of NAX060: A novel semisynthetic berberine derivative in breast cancer cells.
    Pierpaoli E; Fiorillo G; Lombardi P; Salvatore C; Geroni C; Piacenza F; Provinciali M
    Biofactors; 2018 Sep; 44(5):443-452. PubMed ID: 30178609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine hydrochloride IL-8 dependently inhibits invasion and IL-8-independently promotes cell apoptosis in MDA-MB-231 cells.
    Li X; Zhao SJ; Shi HL; Qiu SP; Xie JQ; Wu H; Zhang BB; Wang ZT; Yuan JY; Wu XJ
    Oncol Rep; 2014 Dec; 32(6):2777-88. PubMed ID: 25335112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of anti-inflammatory effects of berberine, and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo.
    Li CL; Tan LH; Wang YF; Luo CD; Chen HB; Lu Q; Li YC; Yang XB; Chen JN; Liu YH; Xie JH; Su ZR
    Phytomedicine; 2019 Jan; 52():272-283. PubMed ID: 30599908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy of theophylline reduces necrotic effect of berberine, induces cell cycle arrest and PARP, HMGB1, Bcl-2 family mediated apoptosis in MDA-MB-231 breast cancer cells.
    Hashemi-Niasari F; Rabbani-Chadegani A; Razmi M; Fallah S
    Biomed Pharmacother; 2018 Oct; 106():858-867. PubMed ID: 30119256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine attenuates high glucose-induced proliferation and extracellular matrix accumulation in mesangial cells: involvement of suppression of cell cycle progression and NF-κB/AP-1 pathways.
    Lan T; Wu T; Chen C; Chen X; Hao J; Huang J; Wang L; Huang H
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):109-16. PubMed ID: 24508662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three Arachidonoylamide Derivatives Inhibit Pro-Inflammatory Genes Expression by Modulating NF-kB and AP1 Activities.
    Gregorelli A; Sgarbossa A; Khan S; Soriente A; De Rosa M; Saturnino C; Menegazzi M
    Med Chem; 2016; 12(7):662-673. PubMed ID: 27140182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine inhibits the proliferation and migration of breast cancer ZR-75-30 cells by targeting Ephrin-B2.
    Ma W; Zhu M; Zhang D; Yang L; Yang T; Li X; Zhang Y
    Phytomedicine; 2017 Feb; 25():45-51. PubMed ID: 28190470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell.
    Yao M; Fan X; Yuan B; Takagi N; Liu S; Han X; Ren J; Liu J
    BMC Complement Altern Med; 2019 Aug; 19(1):216. PubMed ID: 31412862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine hydrochloride attenuates lipopolysaccharide-induced endometritis in mice by suppressing activation of NF-κB signal pathway.
    Fu K; Lv X; Li W; Wang Y; Li H; Tian W; Cao R
    Int Immunopharmacol; 2015 Jan; 24(1):128-32. PubMed ID: 25479718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulinastatin attenuates LPS-induced inflammation in mouse macrophage RAW264.7 cells by inhibiting the JNK/NF-κB signaling pathway and activating the PI3K/Akt/Nrf2 pathway.
    Li ST; Dai Q; Zhang SX; Liu YJ; Yu QQ; Tan F; Lu SH; Wang Q; Chen JW; Huang HQ; Liu PQ; Li M
    Acta Pharmacol Sin; 2018 Aug; 39(8):1294-1304. PubMed ID: 29323338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.
    Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H
    Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine hydrochloride protects against cytokine-induced inflammation through multiple pathways in undifferentiated C2C12 myoblast cells.
    Poudel A; Zhou JY; Mekala N; Welchko R; Rosca MG; Li L
    Can J Physiol Pharmacol; 2019 Aug; 97(8):699-707. PubMed ID: 31026403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-
    Sun X; Chang X; Wang Y; Xu B; Cao X
    Biomed Res Int; 2019; 2019():9241769. PubMed ID: 31341911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1.
    Qi M; Liu X; Zhou Y; Wang H; Zhao Y; Ren J; Xiang J
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo.
    Zhao Y; Jing Z; Lv J; Zhang Z; Lin J; Cao X; Zhao Z; Liu P; Mao W
    Biomed Pharmacother; 2017 Nov; 95():18-24. PubMed ID: 28826092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway.
    Wang B; Yan Y; Zhou J; Zhou Q; Gui S; Wang Y
    Biomed Pharmacother; 2013 Jun; 67(5):357-62. PubMed ID: 23602051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.